Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Here’s What Happened

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares dropped 31.3% during mid-day trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares traded hands during trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Performance

The firm has a market cap of C$23.01 million, a price-to-earnings ratio of -16.50 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company has a 50 day moving average of C$0.10 and a 200 day moving average of C$0.07.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.